• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重波动与代谢功能障碍相关脂肪性肝病风险之间的关联。

Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease.

作者信息

Wang Jin-Ping, Wang Jia-Yang, Sun Pei-Qi, Wang Xue-Wei, Yuan Ze-Ting, Cao Qin, Pan Shu-Ming, Jiang Yuan-Ye

机构信息

Department of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.

Department of Emergency, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.

出版信息

World J Hepatol. 2025 May 27;17(5):103852. doi: 10.4254/wjh.v17.i5.103852.

DOI:10.4254/wjh.v17.i5.103852
PMID:40501466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12149894/
Abstract

BACKGROUND

The global incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased in recent years. It has already been demonstrated that exercise and weight change are associated with the occurrence of MASLD; however, the association between weight fluctuation caused by different exercise intensities and the risk of MASLD remains to be studied.

AIM

To investigate the impact of weight fluctuation and physical activity intensity on the risk of MASLD prevalence.

METHODS

Data from the National Health and Nutrition Examination Survey database including five cycles from 2009 to 2018 were analyzed. The model included variables such as age, sex, and poverty income ratio. Weighted multivariate logistic regression was used to examine the influence of different weight fluctuation patterns within the two time intervals on the prevalence of MASLD. Nonparametric restricted cubic spline curves were used to analyze the non-linear relationship between net weight change and MASLD prevalence.

RESULTS

Among 3183 MASLD cases, the risk of MASLD increased with age for individuals transitioning from non-obese to obese or maintaining obesity, with odds ratio (OR) changing from 8.91 (95%CI: 7.40-10.88) and 11.87 (95%CI: 9.65-14.60) at 10 years before baseline to 9.58 (95%CI: 8.08-11.37) and 12.51 (95%CI: 9.33-16.78) at 25 years. Stable obesity correlated with age-dependent MASLD prevalence escalation, whereas increased physical activity attenuated MASLD risk in this group, with an OR changing from 13.64 (95%CI: 10.59-17.57) to 6.42 (95%CI: 4.24-9.72). Further analysis of the net weight changes revealed a paradoxical risk elevation with intensified physical activity during different time periods.

CONCLUSION

The risk of MASLD increases in individuals transitioning from non-obese to obese or maintaining obesity. High-intensity physical activity is beneficial for MASLD among individuals with stable obesity.

摘要

背景

近年来,代谢功能障碍相关脂肪性肝病(MASLD)的全球发病率有所上升。已有研究表明,运动和体重变化与MASLD的发生有关;然而,不同运动强度引起的体重波动与MASLD风险之间的关联仍有待研究。

目的

探讨体重波动和身体活动强度对MASLD患病率风险的影响。

方法

分析了来自2009年至2018年五个周期的美国国家健康与营养检查调查数据库的数据。该模型纳入了年龄、性别和贫困收入比等变量。采用加权多因素逻辑回归分析两个时间间隔内不同体重波动模式对MASLD患病率的影响。使用非参数限制立方样条曲线分析净体重变化与MASLD患病率之间的非线性关系。

结果

在3183例MASLD病例中,从非肥胖转变为肥胖或维持肥胖的个体中MASLD风险随年龄增加,优势比(OR)从基线前10年的8.91(95%CI:7.40-10.88)和11.87(95%CI:9.65-14.60)变为25年时的9.58(95%CI:8.08-11.37)和12.51(95%CI:9.33-16.78)。稳定肥胖与年龄相关的MASLD患病率升高相关,而该组中身体活动增加会降低MASLD风险,OR从13.64(95%CI:10.59-17.57)变为6.42(95%CI:4.24-9.72)。对净体重变化的进一步分析显示,在不同时间段内,身体活动增强会出现矛盾的风险升高。

结论

从非肥胖转变为肥胖或维持肥胖的个体中MASLD风险增加。高强度身体活动对稳定肥胖个体的MASLD有益。

相似文献

1
Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease.体重波动与代谢功能障碍相关脂肪性肝病风险之间的关联。
World J Hepatol. 2025 May 27;17(5):103852. doi: 10.4254/wjh.v17.i5.103852.
2
The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES.膳食纤维摄入量对代谢功能障碍相关脂肪性肝病患者睡眠模式与肝纤维化之间关联的调节作用:一项来自美国国家健康与营养检查调查(NHANES)的研究
BMC Gastroenterol. 2024 Dec 18;24(1):457. doi: 10.1186/s12876-024-03538-8.
3
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity.中国肥胖儿童血清尿酸与高密度脂蛋白胆固醇比值与代谢功能障碍相关脂肪性肝病的关系
Front Endocrinol (Lausanne). 2025 Jan 8;15:1474384. doi: 10.3389/fendo.2024.1474384. eCollection 2024.
4
Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017-2020.饮食质量和身体活动对美国成年人中与代谢功能障碍相关的脂肪性肝病、代谢功能障碍和病因相关的脂肪性肝炎以及代偿期晚期慢性肝病有影响:2017 - 2020年美国国家健康与营养检查调查(NHANES)
Front Nutr. 2025 Jan 8;11:1505970. doi: 10.3389/fnut.2024.1505970. eCollection 2024.
5
Nonlinear association between body roundness index and metabolic dysfunction associated steatotic liver disease in nondiabetic Japanese adults.日本非糖尿病成年人身体圆润度指数与代谢功能障碍相关脂肪性肝病之间的非线性关联。
Sci Rep. 2025 May 2;15(1):15442. doi: 10.1038/s41598-025-99540-5.
6
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与代谢功能障碍相关脂肪性肝病之间的关联
Front Nutr. 2025 Mar 3;12:1557751. doi: 10.3389/fnut.2025.1557751. eCollection 2025.
7
Relative fat mass and risk of metabolic dysfunction associated steatotic liver disease and severe hepatic steatosis in U.S. adults: analysis of NHANES 2017-2020 data.美国成年人中相对脂肪量与代谢功能障碍相关脂肪性肝病及严重肝脂肪变性风险:基于2017 - 2020年美国国家健康与营养检查调查(NHANES)数据的分析
BMC Gastroenterol. 2025 May 27;25(1):410. doi: 10.1186/s12876-025-04006-7.
8
Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.遵循行星健康饮食指数与代谢功能障碍相关脂肪性肝病:一项横断面研究。
Front Nutr. 2025 Feb 20;12:1534604. doi: 10.3389/fnut.2025.1534604. eCollection 2025.
9
Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.血清铁蛋白基线和轨迹与代谢功能障碍相关脂肪性肝病发病的关系:一项前瞻性队列研究。
Lipids Health Dis. 2024 May 17;23(1):141. doi: 10.1186/s12944-024-02129-6.
10
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.心脏代谢指标与代谢功能障碍相关脂肪性肝病的发病及其向肝纤维化进展之间的关联:一项队列研究
Cardiovasc Diabetol. 2025 Apr 3;24(1):154. doi: 10.1186/s12933-025-02716-6.

本文引用的文献

1
The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective.运动在脂肪性肝病中的作用:最新观点
Liver Int. 2025 Jan;45(1):e16220. doi: 10.1111/liv.16220.
2
Steatotic liver disease.脂肪变性肝疾病。
Lancet. 2024 Nov 2;404(10464):1761-1778. doi: 10.1016/S0140-6736(24)01811-7.
3
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
4
Current status and future trends of the global burden of MASLD.全球 MASLD 负担的现状和未来趋势。
Trends Endocrinol Metab. 2024 Aug;35(8):697-707. doi: 10.1016/j.tem.2024.02.007. Epub 2024 Feb 29.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
6
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial.每周一次胰岛素icodec 与每日一次胰岛素德谷胰岛素在胰岛素初治 2 型糖尿病成人中的比较:ONWARDS 3 随机临床试验。
JAMA. 2023 Jul 18;330(3):228-237. doi: 10.1001/jama.2023.11313.
7
Changing epidemiology, global trends and implications for outcomes of NAFLD.非酒精性脂肪性肝病的流行病学变化、全球趋势及其对结局的影响。
J Hepatol. 2023 Sep;79(3):842-852. doi: 10.1016/j.jhep.2023.04.036. Epub 2023 May 9.
8
Healthy plant-based diets improve dyslipidemias, insulin resistance, and inflammation in metabolic syndrome. A narrative review.健康的植物性饮食可改善代谢综合征中的血脂异常、胰岛素抵抗和炎症。一篇叙述性评论。
Adv Nutr. 2023 Jan;14(1):44-54. doi: 10.1016/j.advnut.2022.10.002. Epub 2022 Dec 17.
9
Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease.健康的生活方式与非酒精性脂肪性肝病患者的死亡率降低有关。
Nutrients. 2022 Sep 14;14(18):3785. doi: 10.3390/nu14183785.
10
Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review.低脂饮食与低碳水化合物饮食治疗非酒精性脂肪性肝病的系统评价
Front Nutr. 2022 Aug 16;9:987921. doi: 10.3389/fnut.2022.987921. eCollection 2022.